Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 17;45(1):61–65. doi: 10.1038/s41440-021-00755-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — Anti-angiotensin II antibody titer. The antibody titer is shown in (A) the high-dose group (N = 9), (B) the low dose group (N = 9), and (C) the placebo group (N = 5). The antibody titer was measured at 0, 7, 14, and 30 days after the first vaccination with AGMG0201 and 7, 14, 30, 60, 90, 180, and 360 days after the second vaccination (B7, B14, B30, B60, B90, B180, and B360), excluding B180 and B360 in the placebo group